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SUMMARY
Epidermal homeostasis requires balanced and coordinated adult stem cell renewal and differentia-
tion. These processes are controlled by both extracellular signaling and by cell intrinsic transcription
regulatory networks, yet how these control mechanisms are integrated to achieve this is unclear.
Here, we developed single-cell Immuno-Detection by sequencing (scID-seq) and simultaneously
measured 69 proteins (including 34 phosphorylated epitopes) at single-cell resolution to study the
activation state of signaling pathways during human epidermal differentiation. Computational
pseudo-timing inference revealed dynamic activation of the JAK-STAT, WNT, and BMP pathways
along the epidermal differentiation trajectory. We found that during differentiation, cells start pro-
ducing BMP2-ligands and activate the canonical intracellular effectors SMAD1/5/9. Mechanistically,
the BMP pathway is responsible for activating the MAF/MAFB/ZNF750 transcription factor network
to drive late-stage epidermal differentiation. Ourwork indicates that incorporating signaling pathway
activation into this transcription regulatory network enables coordination of transcription programs
during epidermal differentiation.
INTRODUCTION
The human epidermis is continuously turned over throughout life, a process that requires precise control
and coordination of stem cell renewal and differentiation. During epidermal homeostasis, proliferating
stem/progenitor cells residing in the basal layer replenish terminally differentiated cells that are shed
from the skin surface (Blanpain and Fuchs, 2006; Solanas and Benitah, 2013; Watt et al., 2006). Human
epidermal stem cells can be maintained in culture and used to regenerate functional epidermis in vivo
upon transplantation and retain their capacity to differentiate in vitro (Barrandon et al., 2012; Green,
2008; Hirsch et al., 2017; Rheinwald and Green, 1975). The process of differentiation is driven forward by
consecutive activation of transcriptional programs, yet the mechanisms underlying their sequence and
timing are not well understood. In the epidermal basal layer, cells receive proliferative signals, predomi-
nantly via the epidermal growth factor receptor, and contact the underlying basement membrane (Watt,
2002; Watt and Huck, 2013). These contacts are mediated by focal adhesions and hemi-desmosomes
that contain integrin b1 and integrin a6, respectively (Watt, 2002; Watt and Huck, 2013). As cells stop prolif-
erating and initiate differentiation, these structures are resolved, allowing the cells to detach from the base-
ment membrane and migrate up toward the epidermal surface. During this migration, the cells undergo
major transitions in transcriptional programs, eventually producing the terminally differentiated keratino-
cytes that form the outermost protective layer of our skin.
TP63 is a key DNA-binding transcription factor in epidermal stem cell renewal and, upon differentiation, its
expression is decreased (Kouwenhoven et al., 2010; Truong et al., 2006). In contrast, other transcription fac-
tors, including KLF4, OVOL2, GRHL3, MAF/MAFB, and ZNF750, are induced (Bhaduri et al., 2015; Koster
and Roop, 2004; Lopez-Pajares et al., 2015; Sen et al., 2012; Wells et al., 2009). Of these, MAF and
MAFB cooperatively regulate a transcription program that includes ZNF750, which subsequently drives
expression of terminal differentiation genes (Lopez-Pajares et al., 2015). This concept of sequential activa-
tion of transcription factors (also called transcription regulatory networks) explains cell intrinsic progression
of epidermal differentiation. Indeed, human keratinocytes differentiate when placed in conditions where
they are not in contact with other cells, for instance, in suspension in methylcellulose or on micro-patterned
islands (Adams andWatt, 1989; Connelly et al., 2010). However, this does not take into account the need for
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regional coordination of differentiation in a tissue context. For instance, the basal, spinous, granular, and
cornified layers of the epidermis are morphologically distinct and can be distinguished using specific
markers, reflecting differences in transcriptional programs. The fact that these are sequentially formed
layers indicates the need for a form of coordination that is not immediately explained by the function of
cell intrinsic transcription factor networks.
Extracellular signaling pathways generally depend on binding of a peptide ligand to the extracellular part
of a transmembrane receptor. This receptor then relays this signal into an intracellular cascade, usually
involving multiple kinases and phosphorylation events, to regulate specific transcription programs. As
such, activation of extracellular signaling pathways may serve as a self-contained timing mechanism to
drive differentiation forward in a tissue and safeguard the irreversibility of the process. Several signaling
pathways (e.g., Integrins, EGF, TGFb, Notch, and BMP) have been implicated in epidermal biology, yet
their temporal dynamics and mechanistic contributions to the control of specific transcription programs
are largely unknown, especially in the context of human epidermis (Beck and Blanpain, 2012; Blanpain
and Fuchs, 2006; Li et al., 2003; Watt, 2002; Watt et al., 2006). For example, the importance of the Bone
Morphogenetic Protein (BMP) pathway in the embryonic morphogenesis of mouse hair follicles and bulge
stem cell behavior during postnatal hair differentiation and cycling in mice is well established (Blanpain and
Fuchs, 2006; Botchkarev and Sharov, 2004; Guha et al., 2004; Lewis et al., 2014; Mou et al., 2016), yet the
contribution of this pathway to human epidermal renewal and differentiation is still poorly understood
(Fessing et al., 2010; Gosselet et al., 2007; Yang et al., 2006).
To study the role of signaling in human epidermal differentiation, we recently described the Immuno-
Detection by sequencing (ID-seq) technology to simultaneously quantify >70 (phospho-)proteins in
many cell populations in parallel (van Buggenum et al., 2016, 2018). This allowed us to screen hundreds
of small molecule kinase inhibitors for their impact on keratinocyte biology. The ID-seq technology entails
highly multiplexed immuno-staining with DNA-barcoded antibodies followed by signal quantification
through high-throughput sequencing. A 10-nt antibody-specific barcode enables deconvolution of the
measured epitope, whereas inclusion of unique molecular identifiers allows accurate count-based quanti-
fication. The fact that these 10-nt barcodes are discrete and specific for each antibody facilitates multi-
plexed detection of 70 (or more) epitopes per treated population of cells. Thus, using ID-seq, the activity
of a range of processes and signaling pathways can be monitored through the activated (phosphorylated)
states of its components (van Buggenum et al., 2018). However, populations of cells rarely display homo-
geneous timing of differentiation (Altschuler andWu, 2010;Wu and Singh, 2012), making it difficult to inves-
tigate the signaling dynamics underlying this process. We therefore set out to study signaling pathway
activity and dynamics during human epidermal cell differentiation at the single-cell level.
RESULTS
scID-seq Allows Robust, Reproducible, and Highly Multiplexed Protein Detection in Single
Cells
To reach single-cell sensitivity and resolution, we redesigned and significantly modified our original ID-seq
technology. The final single-cell (sc) ID-seq workflow includes immuno-staining of cells in suspension fol-
lowed by flow-cytometry-based single-cell distribution into 96-well PCR plates to prepare samples for
sequencing (Figures 1A and S1). A key improvement was the addition of a preamplification step before
adding the cell-specific barcode. Again, the inclusion of a 15-nt unique molecular identifier (UMI) allowed
counting-based quantification and ensured that potential duplication artifacts introduced during sample
preparation could be accounted for (Kivioja et al., 2012). We found that unique barcode counts from wells
containing a single sorted cell were 100-fold higher than from empty wells, indicating that only 1% of the
signal constituted technical background (Figure 1B). Next, we sought to characterize the reproducibility/
confidence of quantification of antibody-derived UMI counts within single cells. For this, we generated a
panel of five antibodies against cell surface (ITGA6 and ITGB1), cytoplasmic (Actin and TGM1), and nuclear
(RNApol2) epitopes, each of which was independently conjugated to nine distinct DNA barcodes, gener-
ating a total pool of 45 antibody-DNA conjugates. Each of these barcodes serves as a technical replicate,
and their concordance therefore reflects the reproducibility of single-cell ID-seq measurements. All of the
barcodes for each of these five antibodies showed very good correlation across cells (R = 0.95–0.99), indi-
cating a low level of noise in scID-seq measurements (Figures 1C and S2). To further validate scID-seq, we
stained human epidermal stem cells simultaneously with ITGB1 antibodies containing either a fluorescent
group or the DNAbarcode.We recorded the FACS-based ITGB1 signal, as well as the ITGB1 DNA-barcode
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counts for individual cells. This revealed that scID-seq counts indeed reflect standard FACS measurements
for the same cell (R = 0.76, Figure 1D). Together, these results establish single-cell ID-seq as a robust and
reproducible method to measure proteins at individual cell resolution. Moreover, the fact that each DNA
barcode is unique to a specific antibody allows antibodies to be multiplexed and measured in each indi-
vidual cell at an unprecedented level.
scID-seq Distinguishes Renewing and Differentiated Epidermal Cells
We applied single-cell ID-seq to monitor the activity of signaling pathways and other cellular processes
during epidermal differentiation using a panel of 70 antibody-DNA conjugates (van Buggenum et al.,
2016, 2018). These antibodies cover a broad range of cellular processes, including cell cycle, DNA damage,
epidermal self-renewal, and differentiation, as well as the intracellular signaling status for the EGF, G-pro-
tein-coupled receptors, calcium signaling, TNFa, TGFb, Notch, WNT, and BMP pathways (van Buggenum
et al., 2018 and Table S1). This panel includes 34 antibodies against phosphorylated epitopes and was
extensively validated (van Buggenum et al., 2018). For 11 of the phosphorylated epitopes we alsomeasured
the non-phosphorylated protein, allowing us to correct for total protein levels by calculating the phosphor-
ylated to total protein ratio per cell. Most of the targeted processes are measured using multiple (three to
five) independent validated antibodies (van Buggenum et al., 2018).
The surface level of ITGB1 reflects a cell’s potential to proliferate and self-renew (Adams and Watt, 1989;
Jones and Watt, 1993; Jones et al., 1995; Watt, 2002; Watt and Jones, 1993). We used FACS isolation of
Figure 1. Single-Cell Immuno-Detection by Sequencing (scID-seq) Enables Robust and Reproducible Protein Detection in Individual Cells
(A) Schematic overview of the scID-seq workflow.
(B) Single-cell-derived antibody counts indicate low technical noise levels in scID-seq. Single cells stained with antibody-DNA conjugates sorted into
individual wells of a 96-well plate and compared with wells where no cells were sorted into using scID-seq (n = 132 with 84 cells and 48 empty wells).
(C) scID-seq reproducibly measures antibody signals in single cells. Independently generated antibody-DNA conjugates were used to stain human
epidermal stem cells. Barcode counts derived from the two barcodes were plotted against each other, indicating high reproducibility of the protein
measurements from the same cell.
(D) scID-seq reflects fluorescent activated cell sorting measurements. ITGB1 levels were measured in human epidermal stem cells using FACS and scID-seq.
Fluorescent signal and scID-seq counts for each cell (n = 84) showed a good correlation (R = 0.76).
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Figure 2. Pseudo-Timing Reveals Dynamic Signaling Pathway Activity over the Course of Epidermal Differentiation
(A) Combining scID-seq with FACS-based sorting on ITGB1 levels. Cells were immuno-stained with fluorescent ITGB1 antibodies in combination with a panel
of 70 Ab-DNA conjugates, FACS sorted based on their ITGB1 levels and subjected to scID-seq.
(B) scID-seq distinguishes ITGB1+ and ITGB1low sorted cells based on known epidermal basal, differentiation, and cell-cycle markers. Distributions of
normalized and scaled scID-seq counts of selected proteins verified the separation of the ITGB1+ and ITGB1low populations.
iScience 9, 412–422, November 30, 2018 415
single cells based on their ITGB1 levels to capture the transitions that underlie the differentiation process
(Figure 2A, see Figure S3 for details of the FACS-isolation). Colony formation assays confirmed the loss of
proliferative capacity in cells expressing low levels of ITGB1 (Figure S4A). After staining with the 70 anti-
body-DNA conjugates, cells were sorted into ITGB1-positive (ITGB+) and ITGB1low populations based
on their fluorescent ITGB1 antibody signal and subjected to scID-seq. After quality control and filtering
(see methods for details), we obtained a dataset of 220 single cells (163 ITGB1+ and 57 ITGB1low, respec-
tively) in which 69 antibody-DNA conjugates were quantified. For each cell, antibody-DNA counts were
normalized for differences in sequencing depth by subsampling. To avoid downstream analyses from be-
ing dominated by the most abundant epitopes, we scaled all antibody counts between 0 and 1 across all
cells. Unsupervised principal-component analysis (PCA) separated the ITGB1low (differentiated) cells from
the ITGB1+ cells, confirming the notion that these represent distinct cell states (Figure S4B). Although we
isolated cells only with respect to their cell surface expression of ITGB1, we found that other proteins dis-
played concordant dynamics. For instance, the basal cell markers ITGA6 and TP63 were also decreased in
the ITGB1low population (Figure 2B). In contrast, this population exhibited higher expression of the differ-
entiation-associated proteins TGM1, Notch1 Intracellular Domain (NICD), and KLF4 (Figure 2B). Further-
more, cell cycle markers, such as Rb-p and cdc2 (reflecting the G1-S and G2-M transitions, respectively),
distinguished these populations very well (Figure 2B). This is consistent with the loss of proliferative capac-
ity during differentiation as observed in our colony formation assay (Figure S4A) and demonstrates that
scID-seq captures molecular events underlying cellular function. Indeed, other antibodies in our panel
also showed quantitative differences between these two cell states in either all or in a subset of the cells
(Figure S4C). Interestingly, many of the measured proteins displayed multimodal distributions, suggesting
underlying subpopulation structures that could reflect transitions over the course of differentiation. This
highlights the richness and complexity of our dataset and indicates the need to incorporate information
on multiple parameters simultaneously in further analyses.
Pseudo-timing Reveals Dynamic Signaling Pathway Activity over the Course of
Differentiation
To obtain insight into the progressive changes in signaling pathway activity that occur over the course of
epidermal cell differentiation, we aimed to order the cells by their relative differentiation state. We hypoth-
esized that this state can be inferred by examining the combination of expression of known basal and dif-
ferentiation markers. We performed PCA on selected markers (ITGB1, ITGA6, TP63, NICD, KLF4, and
TGM1) with established roles and dynamics during epidermal differentiation and ranked the cells based
on the resulting principal components. This revealed that principal component 1 (PC1; explaining 50%
of the variance) recapitulated the expected trajectory of the epidermal differentiation process (Figure 2C).
We calculated the average of 10 cell bins to smoothen the data, revealing that the basal markers ITGA6 and
TP63 are indeed downregulated with distinct kinetics (Figure 2D). Immunohistochemical analysis of human
epidermis showed that this PCA-derived ordering of the cells closely resembles the relative order and
timing of changes of these markers in vivo (Figure S5). Thus, we interpret the scaled and binned PC1-score
as a ‘‘pseudo-time’’ approximation of epidermal differentiation dynamics (Figure 2D).
Next, we mined our data for signaling pathways of which the included antibodies showed concordant ef-
fects over pseudo-time and were statistically significantly different between the ITGB1low and ITGB1+
(Figure S4C, Kolmogorov-Smirnov [K-S] test, p < 0.001). This uncovered several signaling pathways that
displayed dynamic behavior over pseudo-time. For instance, PKB/Akt phosphorylation, measured by
two independent antibodies, was increased upon differentiation as previously described (Figure 2E; Janes
et al., 2009). Besides these expected effects, we found previously unappreciated dynamics in three addi-
tional pathways. The JAK-STAT pathway was activated during differentiation, as evident from increased
phosphorylation of JAK1, STAT1, and STAT5, but not the epidermal growth factor receptor (EGFR)-acti-
vated STAT3 (Figure 2F). In addition, the level of the WNT receptor Frizzled-3 gradually increased with
Figure 2. Continued
(C) Principal-component analysis on known markers orders epidermal cells on their renewal and differentiation status. Top panel: markers used for the
temporal ordering, color intensity represents scaled antibody counts. Bottom panel: cells were ranked on their (scaled) PC1 loading. Vertical lines indicate
the 10-cell bins used to smoothen the data in subsequent analyses.
(D) Dynamics of the markers used for PCA, ordered by pseudo-time (scaled PC1 loading) after smoothening. Data points indicate 10-cell bin mean, and solid
lines represent model fit of the data (third-order polynomial regression).
(E) Dynamics of two independent phosphorylated Akt/PKB antibodies over pseudo-time.
(F–H) Dynamics of antibodies reflecting the JAK-STAT, WNT, and BMP signaling pathways over pseudo-time.
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differentiation, as did the activated/phosphorylated form of its co-receptor LRP6 (Figure 2G). Moreover,
the inactivating serine-9 phosphorylation of GSK3-b increased and then reached a plateau. This modifica-
tion helps stabilize cytoplasmic b-catenin in response toWNT-pathway activation (van Kappel andMaurice,
2017). Finally, the BMP pathway was activated at multiple levels (Figure 2H). Our scID-seq panel included
antibodies for the BMP2/4 ligand, the type 2 BMP receptor, total SMAD1 levels, as well as two distinct an-
tibodies against phosphorylated SMAD1/5/9. Over pseudo-time we observed increasing levels of the
ligand, the receptor, as well as phosphorylated SMADs, reflecting activation of the BMP pathway during
differentiation (Figure 2H). As our cells are cultured in a defined medium in the absence of feeder cells,
the signals that activate these pathways are therefore likely to be generated by the cells themselves.
Indeed, the increase of the BMP2/4 ligand is consistent with such regulation by the BMP pathway
(Figure 2H).
BMP Signaling Stimulates a Terminal Epidermal Differentiation Transcription Program
To validate our findings on the activation of the BMP pathway, we induced differentiation of proliferating
epidermal cells in culture by inhibiting EGF signaling (Kolev et al., 2008; Mulder et al., 2012). Samples were
collected at 6, 12, 24, and 48 hr after the addition of either vehicle (DMSO) or the EGFR inhibitor AG1478.
RT-qPCR analysis showed that mRNA expression of the early differentiationmarker periplakin (PPL) and the
late differentiation marker TGM1 reflected the progression of differentiation over time (Figure 3A). In line
with our scID-seq results, mRNA expression of the BMP2 ligand was activated upon induction of differen-
tiation (after the 12-hr time point), whereas the classical BMP-pathway target gene ID2 was induced at a
subsequent stage (after 24 hr, Figure 3A). This induction was dependent on both BMP-ligand binding to
the extracellular part of the receptor and intracellular BMPR kinase activity, as a recombinant version of
the natural BMP-antagonist noggin and the small molecule kinase inhibitor DMH1 blocked ID2 expression
(Figures S6A and S6B). Moreover, the observed induction of BMP2 and ID2 was further validated in cells
undergoing calcium-induced differentiation (Figure S6C, data from Kretz et al., 2012). Thus, the BMP
pathway is indeed activated during epidermal differentiation in vitro. To investigate BMP pathway activity
in vivo, we performed immuno-staining with antibodies against phosphorylated SMAD1/5/9 on human
skin. The epidermal basal layer was visualized through co-staining with a keratin-14 antibody, and we coun-
terstained the DNA of all cells with DAPI (Figure 3B). Consistent with our scID-seq and RT-qPCR results, the
signal from the p-SMAD1/5/9 antibody was increased in the differentiated (keratin-14 negative) layers of
human epidermis, confirming that BMP signaling is activated during differentiation in vivo.
These results suggest that BMP signaling may serve as a positive feedforward loop to stimulate
epidermal differentiation gene expression. To test this hypothesis, we treated cells with AG1478
for 96 hr in the absence or presence of the small molecule BMP receptor inhibitor DMH1 and
monitored global gene expression by RNA sequencing. Vehicle-treated cells G DMH1 were included
as controls. PCA indicated that the transcriptomes of non-differentiated and differentiated cells were
markedly different (Figure 3C, PC1; explaining 76% of the variance). In addition, PC2 (5% of variance)
distinguished the DMH1 treated and non-treated differentiated cells, reflecting a transcription program
that depends on the BMP pathway (Figure 3C). Notably, vehicle control cells were virtually indistinguish-
able from control cells treated with DMH1, indicating that BMP signaling specifically regulates differen-
tiation but not proliferation/renewal programs. Moreover, the genes that were dependent on the BMP
pathway activity showed highly significant enrichment of genes involved epidermal keratinization and
cornification, indicating that BMP signaling drives transcriptional changes toward terminal differentiation
(Figure 3D).
The Terminal Differentiation Transcription Factors MAF/MAFB Are Downstream Targets of
the BMP Pathway
We further explored the mechanistic role of the BMP pathway in epidermal differentiation by investigating
the gene expression program that is influenced by stimulation with recombinant BMPs. First, we treated
cells with different BMP ligands and measured the induction of the late differentiation marker transgluta-
minase I (TGM1) at the protein level. This indicated that most recombinant ligands led to a robust increase
of TGM1 (Figure S7A). Moreover, simultaneous treatment of cells with the EGFR inhibitor AG1478 and BMP
ligands resulted in a synergistic increase of TGM1 protein levels, highlighting opposing roles for these
pathways in epidermal biology (Figure S7B). Next, we performed RNA sequencing analysis on cultured hu-
man epidermal cells treated with vehicle, AG1478, BMP2/7, or AG1478 + BMP2/7 for 48 hr (Figures S7C and
S7D). Comparing the mRNA profiles of these conditions revealed the genes that were responsive to the
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addition of recombinant BMP2/7 and were also dynamically expressed during AG1478-induced differenti-
ation (Figure S7E). As expected, the top most BMP-responsive genes included the ID gene family. More-
over, genes involved in terminal differentiation, including TGM1, MAF, MAFB, and ZNF750, displayed
BMP-induced expression changes (Figure S7F), confirming the results obtained with the BMP pathway
inhibitor DMH1 (Figure 3D). The MAF/MAFB and ZNF750 transcription factor axis drives the epidermal ter-
minal differentiation transcription program (Lopez-Pajares et al., 2015). These results imply that activation
of BMP signaling functions upstream of this axis.
Figure 3. BMP Signaling Stimulates a Terminal Epidermal Differentiation Transcription Program
(A) BMP2 ligand and its downstream target gene ID2 are activated during in vitro keratinocyte differentiation. Human
keratinocytes were induced to differentiate with AG1478 (or DMSO as a control), and samples were harvested at the indicated
time points. RT-qPCR analysis was performed for PPL, TGM1, BMP2, and ID2 (n = 3, data represented as meanG SD).
(B) BMP signaling is activated during epidermal differentiation in vivo. Sections of human foreskin were stained with antibodies
against phosphorylated SMAD1/5/9. DAPI and K14 antibodies were used to counterstain all nuclei and basal cells, respectively.
Scale bar represents 50 mm. Dashed line indicates the basement membrane separating the dermis and epidermis.
(C) Activation of BMP signaling regulates a transcriptional program during epidermal differentiation. Principal-
component analysis of human keratinocytes induced to differentiate with AG1478 (or the DMSO control) for 96 hr in the
presence of the BMP receptor inhibitor DMH1, followed by RNA sequencing analysis (n = 3, except DMSO control n = 2).
(D) BMP-dependent genes are involved in late differentiation processes. Top enriched terms from a gene ontology
overrepresentation analysis (hypergeometric test, FDR<0.01) of differentially expressed genes between the AG1478 and
AG1478+DMH1 samples.
418 iScience 9, 412–422, November 30, 2018
To identify potential transcriptional targets downstream of the BMP pathway, we performed chromatin
immunoprecipitation followed by sequencing (ChIP-seq), using H3K4me3 ChIP-seq signals at the transcrip-
tion start site (TSS) as a proxy for changes in transcriptional activity of a gene. We did not manage to obtain
high-quality SMAD1 ChIP-seq profiles and reasoned that the changes in H3K4me3 signals might provide a
first indication of downstream BMP signaling targets. Proliferating epidermal stem cells were treated with
vehicle or recombinant BMP2/7 (in combination with AG1478) for 6 hr, after which they were harvested for
ChIP-seq analysis. This identified 135 genes that showed a significant increase in H3K4me3 signal (FPKM,
p < 0.01, outlier statistics) at their TSS, suggestive of increased transcriptional activity (Figures 4A and 4B).
De novomotif discovery on the 2.5 kb up and downstream of these TSS regions revealed enrichment of an
SMAD-like motif (p < 1031, Figure 4A). This is in line with the notion that these genes are responsive to
BMP signaling. This set included the classical BMP targets ID1, 2 and 3, demonstrating that our experi-
mental approach identified known direct BMP pathway target genes (Figure 4B). In addition to this, the ter-
minal differentiation regulating transcription factors GRHL3, MAF, and MAFB were among the top set of
immediate BMP targets (Figures 4B and 4C). In contrast, the key MAF/MAFB target gene ZNF750 was
not directly regulated downstream of the BMP pathway as determined by H3K4me3 ChIP-seq signal (Fig-
ure 4C). A limitation of this experiment is that we performed ChIP-seq analysis after 6 hr of treatment. Some
of the observations may therefore reflect secondary effects of BMP treatment. In general, we would expect
direct BMP target genes to show an immediate-early response to activation of the pathway. We tested this
by treating proliferating keratinocytes with recombinant BMP2/7 for 2 hr followed by RT-qPCR analysis. This
revealed that both MAF and MAFB mRNA levels were induced at this early time point, as was the classical
BMP target gene ID2 (Figure 4D). In contrast, ZNF750 was not induced, nor were the differentiationmarkers
periplakin (PPL) and TGM1. These results place BMP pathway activation immediately upstream of theMAF/
MAFB transcription factors. These factors subsequently drive terminal differentiation programs through,
among others, ZNF750 (Figure 4E, Lopez-Pajares et al., 2015).
DISCUSSION
We developed single-cell Immuno-Detection by sequencing (scID-seq) as a highly multiplexed single-cell
(phospho-)proteomics approach based on our previously published ID-seq method. The combination of
these two related techniques constitutes a toolbox spanning cell population-based drug screens to single-
cell follow-up. This allows exploration of the heterogeneity of drug effectivity within a cell population, as
well as effects on signaling and other cellular processes within individual cells after drug treatment. In prin-
ciple, scID-seq can be applied to any biological system in which single cells can be obtained and high-quality
antibodies are available. Moreover, scID-seq in combination with FACS-based sorting allows enrichment of
specific and/or rare cell types a priori. Using this approach, we enriched for spontaneously differentiating cells
based on their surface ITGB1 levels to study signaling pathway activity in individual human epidermal cells
with distinct differentiation states. Measuring 69 (phospho-)proteins per cell demonstrated that, among
others, BMP signaling is activated along the differentiation trajectory. Mechanistically, the BMP pathway stim-
ulates the MAF/MAFB/ZNF750 axis to induce a transcriptional program during late-stage epidermal differ-
entiation. Previous studies provided indications that stimulation with exogenous BMP ligands increases
the expression of cell cycle inhibitory factors and select differentiation-associated genes, suggesting involve-
ment of this pathway in human epidermal differentiation (Botchkarev, 2003; Fessing et al., 2010; Gosselet
et al., 2007; Li et al., 2003; Yang et al., 2006). However, its timing and function during the differentiation pro-
cess remained unclear. Using RNA sequencing and H3K4me3 ChIP-seq analysis in combination with inhibi-
tion and stimulation, we found that BMP signaling activation drives a terminal differentiation transcription
program and the MAF/MAFB/ZNF750 transcription factor axis (Figures 3 and 4). Our findings have implica-
tions for our view on the progressing nature of keratinocyte differentiation. First, regional signaling pathway
activity plays crucial roles in patterning and tissue specification during (early) development. Our findings
implicate BMP pathway activation as an integral part of the transcription factor network stimulating epidermal
differentiation. As the BMP ligand is produced and excreted by the cells into their local environment, our re-
sults provide amechanistic explanation for coordinated expression program progression in a zonated fashion
in a tissue context. Second, the identification of the cell intrinsic activation of the BMP pathway through up-
regulation of its ligand BMP2, in combination with our observation that the BMP pathways is responsible for
the stimulation of a specific transcriptional program including late differentiation regulators (e.g., MAF/
MAFB, DLX3 and OVOL2), suggests that this pathway is involved in a self-sustaining loop that keeps driving
epidermal differentiation forward. Taken together, our results reveal a mechanistic role for BMP signaling in
human epidermal differentiation and indicates that activation of (potentially autocrine) signaling loops en-
ables cells to coordinate their transcriptional programs and ensure progressive differentiation.
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Figure 4. The TerminalDifferentiationTranscription FactorsMAF/MAFBAreDownstreamTargets of theBMPPathway
(A) ChIP-sequencing of the active gene mark H3K4me3 identifies potential downstream targets after BMP stimulation.
Scatterplot of normalized, log-transformed H3K4me3 ChIP-seq signals from cells incubated with and without
recombinant BMP2/7 in the context of EGFR inhibition. Genes with increased or decreased H3K4me3 signals (p < 0.01,
outlier statistics) at their transcription start site are highlighted in red and blue, respectively. Examples of relevant
activated and inhibited genes are indicated.
(B) Gene promoters of genes with induced H3K4me3 levels are enriched in an SMAD-like motif. The sequences (TSS G
2.5 kb) of the genes with induced H3K4me3 levels were subjected to a de novo motif enrichment search. One of the
enriched motifs showed high similarity to a known SMAD motif.
(C) H3K4me3 genome-browser tracks of ID2, MAF, MAFB, and ZNF750.
(D) MAF and MAFB, but not ZNF750, are immediate-early responding genes downstream of BMP stimulation. RT-qPCR
analysis of the indicated genes 2 hr after treatment with vehicle or recombinant BMP2/7 (n = 3, data represented asmeanG SD).
(E) Model of the transcription regulatory network activated by BMP signaling during epidermal differentiation.
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Limitations of the Study
Our work establishes that scID-seq has the potential to quantify many antibodies with high sensitivity in in-
dividual cells. As with any antibody-based approach, the quality of the antibodies is a limiting factor and
should be defined carefully. Our current iteration of scID-seq, which includes FACS-based single-cell isola-
tion, is limited in the number of cells that can be practically processed in parallel. A solution would be
replacing the FACS and sample preparation with droplet-microfluidics, as in the Ab-seq approach, for
instance (Shahi et al., 2017). With regards to our biological question, the data contains a comparatively
low coverage of intermediate differentiation stages for the pseudo-timing analysis. As a consequence,
the relative timing of the pathways that show dynamics during that stage cannot, currently, be temporally
segregated at high resolution. Finally, the H3K4me3 ChIP-seq we performed is taken as a proxy for tran-
scriptional changes and we cannot exclude some contribution of secondary or indirect responses that
are not de facto immediately downstream of BMP activation. We therefore chose to include additional
experiments to provide further indications of direct effects on the MAF/MAFB/ZNF750 axis.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Sequencing data was deposited in the Gene Expression Omnibus (GEO) repository under series number
GSE115926.
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Figure S1: Schematic representation of the single-cell ID-seq work-flow. The scID-seq 
procedure entails crucial modifications compared to the original ID-seq protocol. First, cells are 
stained with the antibody-DNA conjugates in suspension, to allow single-cell sorting. Second, 
a pre-amplification step increased the yield and complexity of the single-cell libraries. This pre-
amplification is done prior to adding a cell-specific barcode to the PCR products. From this 
point on, the library preparation is the same as described for ID-seq. Related to Figure 1. 
 
 
 
 
 
Figure S2: Nine technical replicates per individual cell highlight the reproducibility of scID-seq. 
Cells were stained with a mixture of 45 antibody-DNA conjugates consisting of 5 different 
antibodies that were each separately conjugated to 9 independent DNA-barcodes. The 
Pearson correlation among the 9 measurements for each antibody across individual cells 
indicates the reproducibility of scID-seq to quantify relative protein levels. Related to Figure 1. 
 
 
  
 
 
 
Figure S3: ITGB1 FACS strategy. (A-C) single cells were gated using forward and side-scatter 
characteristics. (D) Cells stained with low ITGB1-FITC levels were gated and sorted into 
individual wells (ITGB1low). ITGB1+ cells were selected from the total population. (E) 
Secondary antibody only stained cells indicate the specificity of the ITGB1-FITC staining. 
Related to Figure 2.   
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Figure S4: scID-seq on cells selected on ITGB1 level by FACS. (A) Cells with low ITGB1 surface 
levels represent differentiated keratinocytes. Cultured human keratinocytes were isolated 
based on their ITGB1 surface expression by FACS and subjected to colony formation assays. (B) 
ITGB1+ and ITGB1low cells display distinct scID-seq profiles. Human keratinocytes were 
subjected to staining with a panel of 70 antibody-DNA conjugates, isolated based on their 
ITGB1 surface level by FACS and analyzed with scID-seq. Principal component analysis 
separated the ITGB1+ and ITGB1low populations. (C) Individual antibodies display dynamics 
between ITGB1+ and ITGB1low cell populations. Distributions of scaled signals of ITGB1+ and 
ITGB1low populations for 70 antibody-DNA conjugates. Statistically different distributions are 
indicated (Kolmogorov-Smirnov test, p<0.001). Related to Figure 2. 
  
 Figure S5: Dynamics of known markers used to derive the pseudo-time line as assessed by 
immunohistochemical staining of human epidermis. Publicly available IHC staining of validated 
antibodies against the indicated epidermal marker proteins. Data from the human protein 
atlas. Related to Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITGA6 NOTCH1TP63ITGB1
ITGB1  : basal layer & basement membrane staining, rapid decrease.
ITGA6  : basal layer & basement membrane staining, rapid decrease.
TP63  : basal layer staining, slow decrease.
NOTCH1 : throughout the epidermis, cell membrane staining in basal layer,
      the activated Notch Intracellular Domain localises to the nucleus in the
    suprabasal layers during differentiation.
KLF4  : increased expression in suprabasal layers during differentiation.
Dashed line indicates the separation of the dermis and the epidermis by the basement membrane.
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Figure S6: The BMP pathway target gene ID2 is induced during differentiation in a BMP-BMPR 
interaction dependent manner. (A) Human keratinocytes were induced to differentiate with 
the EGFR inhibitor AG1478 in the presence or absence of recombinant noggin for 48 hours and 
subjected to RT-qPCR analysis of the ID2 gene. (B) BMP2 and ID2 mRNA expression is induced 
during a time-course of calcium induced differentiation. Related to Figure 3. 
  
 
 
Figure S7: Stimulation with recombinant BMPs induces differentiation gene expression. (A) 
Recombinant BMPs stimulate endogenous TGM1 protein expression. Cells were stimulated 
with the indicated recombinant BMP proteins for 48 hours and subjected to In-Cell-Western 
analysis using TGM1 specific antibodies. Measurements were corrected for cell density using 
the DNA staining agent DRAQ5. n=3 -/+ SD (B) Recombinant BMPs and AG1478 syngergise to 
stimulate endogenous TGM1 protein expression. Cells were stimulated with the indicated 
recombinant BMP proteins for 48 hours in combination with the EGFR inhibitor AG1478 and 
subjected to In-Cell-Western analysis using TGM1 specific antibodies. Measurements were 
corrected for cell density using the DNA staining agent DRAQ5. n=3 -/+ SD. (C) Recombinant 
BMPs, AG1478 and the combined treatment lead to distinct transcriptional responses. Cells 
were stimulated with the indicated treatments for 48 hours and subjected to RNA-sequencing. 
Principal component analysis of differentially expressed genes indicates condition specific 
transcriptional effects. (D) Identification of differentially expressed genes per condition. 
Volcano plots indicate the log2 fold-change of mRNA expression between vehicle and the 
indicated condition on the x-axis. The y-axis represents the -log10 transformed p-value (FDR 
corrected t-test). (E) Hierarchical clustering highlights condition specific differences in 
transcriptional responses. Heatmap of differentially expressed genes (z-score normalised 
across the samples) clustered on Pearson's correlation with average linkage for both genes and 
samples. (F) 48 hours treatment with recombinant BMPs stimulates expression of transcription 
factors involved in late epidermal differentiation. Related to Figure 3. 
 
 
 
  
Transparent methods 
 
Cell culture and reagents 
Primary pooled human epidermal stem cells derived from foreskin were obtained from Lonza. 
Cells were cultured and expanded as previously reported (Gandarillas and Watt, 1997). 
Briefly, cells were cultured on a feeder layer of J2-3T3 cells in FAD medium (Ham’s F12 
medium/Dulbecco’s modified Eagle medium (DMEM) (1:3) supplemented with 10% batch 
tested fetal calf serum (FCS) and a cocktail of 0.5 µg/ml of hydrocortisone, 5 µg/ml of insulin, 
0.1 nM cholera enterotoxin, and 10 ng/ml of epidermal growth factor) supplemented with 
Rock inhibitor (Y-27632, 10 µM). J2-3T3 cells were cultured in DMEM containing 10% bovine 
serum and inactivated with Mitomycin C (SCBT) upon seeding the epidermal stem cells. For 
experiments epidermal stem cells were transferred to Keratinocyte Serum Free Medium 
(KSFM) supplemented with 0.2 ng/ml Epidermal Growth Factor and 30 μg/ml bovine pituitary 
extract from Life Technology until 70% confluent. Cells were treated with AG1478 (10 μM, 
Calbiochem), DMH-1 (1 µM, RND systems) or BMP2/7 (200 ng/ml, R&D systems). All media 
were supplemented with 1% penicillin/streptomycin antibiotics. 
Antibody conjugation with dsDNA barcodes 
Antibodies and dsDNA were functionalized and conjugated as described (van Buggenum et 
al., 2016). Antibody details are provided in supplemental Table 1. In short, antibodies were 
functionalized with NHS-s-s-PEG4-tetrazine (Jena Bioscience) in a ratio of 1:10 in 50 mM 
borate buffered Saline pH 8.4 (150 mM NaCl). Then, N3-dsDNA was produced and 
functionalized with DBCO-PEG12-TCO (Jena Bioscience) in a ratio of 1:25 (oligo list). Finally, 
purified functionalized antibodies were conjugated to purified functionalized DNA by 4-hour 
incubation at room temperature in borate buffered saline pH 8.4 in a ratio of 4:1 respectively. 
The reaction was quenched with an excess of 3,6-diphenyl tetrazine. The conjugation 
efficiency and quality were checked on an agarose gel, confirming that a substantial amount 
of DNA conjugated with the antibody. Ultimately, conjugates were equally pooled for 
staining’s in scID-seq. 
Immunostaining and single-cell sorting 
Cells (> 3 x 106) were harvested with trypsin and cross-linked in suspension by incubating for 
10 minutes with 4% paraformaldehyde (PFA) in PBS following a quenching step of 5 minutes 
with 125 mM Glycine in PBS. Removal of PFA and Glycine occurred through washing twice 
with wash buffer (0.1x Pierce™ Protein-Free Blocking Buffer from Thermo in PBS). Then, cells 
were blocked in 500µl blocking buffer (0.5x 0.1x Pierce™ Protein-Free Blocking Buffer, 200 
µg/ml boiled salmon sperm DNA, 0.1% Triton-X 100, in PBS) at room temperature for 30-60 
min. Staining with the conjugate mix occurred overnight at 4°C in 500 µl blocking buffer and 
pre-staining’s were performed at room temperature for 1-2 hours. After each staining, cells 
were washed 3x in 5ml wash buffer. Cells were sorted single cell with the BD FACSAria SORP 
flow cytometer (BD biosciences) in 96 well PCR plates containing 1µl release buffer (10 mM 
DTT in 15mM Tris, pH 8.8) and 7µl Vapor-lock (Qiagen). For selection of ITGB1 negative cells, 
a primary and secondary pre-stain was done with 2.5 µg/ml anti-ITGB1 (P4D1) and 1:1000 
Alexa488 goat anti-mouse (Life technology, 1484573). Plates were stored at -20°C until use. 
Barcoding and library preparation for next generation sequencing 
For the library preparation 3 PCR steps were performed to amplify the antibody barcodes and 
to add barcodes specific for the well and the plate of each cell. The barcoding occurred with 
the same sequences used in ID-seq (van Buggenum et al., 2018). For the first PCR step 15 
cycles were run after adding to each well a 4 µl reaction mix containing the Herculase II Fusion 
DNA Polymerase (Agilent), dNTPs, 5x Herculase buffer and 0.1µM amplification primers 
(Forward 5ʹ-CACGACGCTCTTCCGATCT-3ʹ, Reverse 5ʹ- TCGCTTATCTGTTGACTGAT-3ʹ). Directly 
after the first PCR step, 5 extra cycles were run after adding 1 µl mix containing Herculase 
buffer 0.2 µM forward amplification primer and 0.2 µM reverse well barcoding primer. Then 
all material was pooled per plate, Vapor-lock was removed and a clean-up was performed 
with the QIAquick PCR Purification Kit, an EXO1 treatment to degrade remaining primers 
followed by another purification. Another 5 cycles were run in PCR 3 with a 20 µl reaction 
containing pooled and purified plate sample and 0.1 µM plate barcoding primers (Fw_long 5ʹ- 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC 
TCTTCCGATCT -3ʹ and specific plate reverse). After repeating the clean-up, the libraries were 
checked on agarose gel and with the Bioanalyzer (Agilent) to confirm the size of the DNA 
fragments (expected size around 185 bp).      
scID-seq data analysis 
Sequence data from the NextSeq500 (Illumina) was demultiplexed using bcl2fastq software 
(Illumina). Then, all reads were processed using our dedicated R-package (van Buggenum et 
al., 2018). In short, the sequencing reads were split using a common “anchor sequence” 
identifying the position of the UMI sequence, Barcode 1 (antibody specific) and Barcode 2 
(well specific) sequence. After removing all duplicate reads, the number of UMI sequences 
were counted per barcode 1 and 2. Finally, barcode 1 (“antibody)” and barcode 2 (‘well’) 
sequences were matched to the corresponding. For scID-seq, a threshold was set based on 
the total UMI count per well difference between high- and low-quality cells or empty wells. 
Antibodies with a median of <10 counts per cell were removed from the dataset. Cells that 
displayed strong outliers for a single antibody (cut-off > 5x standard deviation of the mean of 
the population) were removed from the analysis. After this, cells were normalized through 
subsampling and antibody counts were normalized on a scale from 0 to 1 using the formula 
(x-min(x))/(max(x)-min(x)). Principal component analysis was done with the R-package 
“pcaMethods”. Additional statistical analysis and visualization of the data was done in R and 
Excel.   
Colony formation assays 
Epidermal stem cells were sparsely seeded on a feeder layer in a 6 well plate (500 cells/well) 
and cultured for at least 7 days to form colonies. After colony formation, cells were washed 
with PBS and fixed by incubating 10 minutes with 4% paraformaldehyde (PFA) in PBS. PFA 
removal occurred with 3 PBS washes. For the imaging of the colonies, a DNA stain was 
performed with DRAQ5 (1:4000, Biostatus) for 1 hour at room temperature. After 3 PBS 
washes, plates were scanned with the Odyssey system and the number of colonies quantified. 
 
Immunostaining of human skin sections 
Frozen sections of human foreskin were a kind gift from Prof. Fiona Watt and were obtained 
with informed consent and appropriate ethical review. Sections were fixed for 15 minutes 
with 4% paraformaldehyde, followed by 3 washes with PBS and permeabilisation with 0.2% 
triton-X100 in PBS for 10 minutes at RT. After blocking with 10% Bovine Serum in PBS for 1 
hour, the sections were stained with antibodies against phosphorylated-SMAD1/5/9 (41D10, 
Cell Signaling Technologies) at 1:200 dilution in blocking buffer overnight at 4 degrees Celsius. 
Sections were washes 3x with PBS and stained with secondary antibodies (1:2000 dilution) 
and DAPI (1:5000) for 90 minutes at RT. After mounting on a microscopy slide, images were 
acquired using a Leica IR laser confocal microscope. 
 
RT-qPCR 
Isolated RNA (Quicki-RNA TM MicroPrep, Zymo Research) was used for quantitative PCR 
analysis using iQTM SYBR Green Supermix with 20µM reaction volume, scanned on CFX-96 
machine. Per gene, -2^Ct values were calculated and normalized to 18S RNA levels.  
 
Transcriptome analysis with CEL-seq2  
Isolated RNA (Qucki-RNA TM MicroPrep, Zymo Research) was used for transcriptome analysis 
via a slightly modified CEL-seq2 procedure (Hashimshony et al., 2016). See Table 1 primer 
sequences. In short, 100 pg purified RNA was used in 2 µl reverse transcription reactions 
containing Maxima H minus reverse transcriptase (ThermoFisher). The reactions were 
covered with Vapor-Lock (7 µl, Qiagen).  Different primer sequences were designed and used 
(Table 1), allowing 63 nt long read 1 of mRNA, and 14 nt long read 2 with the sample barcode 
and UMI. NextSeq500 (Illumina) was used for sequencing.  
 
Table 1. Primer sequences used during CEL-seq2 procedure. 
Reverse 
transcription 
primer 
5’GCCGGTAATACGACTCACTATAGGGGTTCAGACGTGTGCTCTTCCGATC 
TNNNNNNNN[6ntsamplebarcode]TTTTTTTTTT TTTTTTTTTTTTTTV3’ 
random-
octamer-primer 
for reverse 
transcription of 
amplified RNA 
5’CACGACGCTCTTCCGATCTNNNNNNNN3’ 
library PCR 
Primers 
5’AATGATACGGCGACCACCGAGATCTACA 
CTCTTTCCCTACACGACGCTCTTCCGATCT3’ 
5’CAAGCAGAAGACGGCATACGAGAT[6ntind 
ex]GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC3’ 
 
CEL-seq2 data analysis 
CEL-seq2 sequencing data was processed using as described (Hashimshony et al., 2016). In 
brief, high quality reads were filtered, and used for mapping. In brief, the count matrix was 
loaded as Seurat object, and used to visualize number of total UMI counts, number of genes 
and number of mitochondrial genes per sample. One out of three vehicle controls in the 
DMH-1 experiment did not pass the QC checks (with 50% less reads/sample) and was 
removed from further analyses. The count matrix was loaded into DESEq2 data object, to 
allow easy normalization, filtering, PCA and differential expression analysis. For analysis of 
the CEL-seq2 data, the DESeq2 R-package (Love et al., 2014) was used to normalize UMI 
counts, perform PCA analysis and determine differential expressed genes. Gene Ontology 
overrepresentation analysis was performed using the GeneTrail webtool (Backes et al., 2007) 
 
ChIP-sequencing 
Cells in KSFM (2.5x106) were incubated with vehicle/DMSO or BMP2/7+AG1478 for 6 hours. 
After harvesting by trypsinisation, the cells were cross-linked with 1% formaldehyde in PBS 
for 10 minutes, quenched for 5 minutes with 125 mM glycine in PBS and washed in PBS at 4 
degrees Celsius. Cross-linked cells were incubated 4 hours in lysis buffer (5 mM Tris-HCl pH 
8.0, 85mM NaCl, 0.5% NP40, 1X PIC) on ice, following 50 strokes with a dounce homogenizer 
to enrich for nuclei. Nuclei were sonicated in sonication buffer (50 mM Tris-HCl pH 8.0, 10 
mM EDTA, 0.1% SDS, 150mM NaCl and 0.5% deoxycholic acid) to get an average chromatin 
fragment length of 500 bp. Chromatin extracts were incubated with 1 µg H3K4me3 antibody 
(ab8580, AbCam) overnight. Antibodies were captured for 4 hours with 100 µl protein G-
coated magnetic beads (Life Technology). Subsequently, beads were washed 5X in RIPA 
buffer. The retrieved chromatin was reverse cross-linked overnight at 65°C followed by a 1-
hour incubation step with proteinase K (1µg/µl) and RNAse A (1µg/µl) at 37°C. The DNA was 
purified with the Qiaquick PCR purification kit. Using the KAPA Biosystems kit (#KK8504), 
between 0.5 and 5ng ChIP-derived DNA was trimmed, A-tailed, provided with Nextflex 
adaptors and amplified with 10 PCR cycles. Subsequently, DNA was size-selected with the E-
Gel® iBase™ Power System (Invitrogen) to purify for fragments between 300 and 400bp. The 
libraries were quantified on the Agilent 2100 Bioanalyzer and evaluated by qPCR to confirm 
representation of enrichments at specific loci. The libraries were sequenced with the 
Nextseq500. Reads were quality checked and aligned to the human hg19 genome with the 
Burrows-Wheeler Alignment tool (BWA) and processed with SAMtools to generate BAM files. 
Peaks were called from BAM files using “Model-based analysis of ChIP-Seq version 1.4” 
(MACS14) with a p-value cut-off of 1x10-8. The ratio of the fragments per kilobase per million 
reads (FPKM) values of the called H3K4me3 peaks were z-score transformed and subjected 
to outlier statistics assuming a normal distribution. De novo motif discovery was performed 
with the Trawler software (Dang et al., 2018). The enriched motifs were compared to known 
motifs in the JASPAR database using PWMtools (http://ccg.vital-it.ch/pwmtools). 
 
Data and Software Availability 
All sequencing data are available from GEO under series number GSE115926. 
 
